XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Statements of Assets and Liabilities - USD ($)
Sep. 30, 2023
Dec. 31, 2022
ASSETS    
Investments at fair value: $ 275,502,000 [1] $ 149,586,000 [2]
Cash and cash equivalents 18,064,000 187,398,000
Interest receivable 1,186,000 0
Deferred offering costs 70,000 382,000
Receivable for issuance of common shares 99,266,000 0
Unrealized appreciation on foreign currency forward contracts 1,905,000 686,000
Receivable for investments sold 14,000 0
Total assets 396,007,000 338,052,000
LIABILITIES    
Payable for investments purchased 31,520,000 149,464,000
Management fees payable 400,000 33,000
Income incentive fee payable 1,896,000 0
Board of Managers fee payable 0 33,000
Accrued expenses and other liabilities 723,000 757,000
Total liabilities 34,539,000 150,287,000
Commitments and contingencies (Note 7)
NET ASSETS    
Common shares 350,000 186,000
Additional paid in capital 358,183,000 186,232,000
Distributable earnings (loss) 2,935,000 1,347,000
Total net assets 361,468,000 187,765,000
Total liabilities and net assets $ 396,007,000 $ 338,052,000
Net asset value per share (in dollars per share) $ 10.32 $ 10.07
[1] Unless otherwise indicated, issuers of debt investments held by the Company (which such term “Company” shall include the Company’s subsidiaries for purposes of this Schedule of Investments) are denominated in dollars. All debt investments are income producing unless otherwise indicated.
[2] Unless otherwise indicated, issuers of debt investments held by the Company (which such term “Company” shall include the Company’s subsidiaries for purposes of this Schedule of Investments) are denominated in dollars. All debt investments are income producing unless otherwise indicated.